{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:31:28Z","timestamp":1793817088512,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Science Foundation of China","award":["82074292"],"award-info":[{"award-number":["82074292"]}]},{"name":"the National Science Foundation of China","award":["82405262"],"award-info":[{"award-number":["82405262"]}]},{"name":"Natural Science Foundation of Jiangsu Province of China","award":["BK20230447"],"award-info":[{"award-number":["BK20230447"]}]},{"name":"Jiangsu Province of Youth Science and Technology Talent Nurturing Project","award":["JSTJ-2024-452"],"award-info":[{"award-number":["JSTJ-2024-452"]}]},{"name":"Jiangsu Traditional Chinese Medicine Science and Technology Development Project","award":["QN202202"],"award-info":[{"award-number":["QN202202"]}]},{"name":"Luo LinXiu Teacher Development Fund Project","award":["LLX202312"],"award-info":[{"award-number":["LLX202312"]}]},{"name":"NATCM's Project of High-level Construction of Key TCM Disciplines","award":["GSPZDXK-FJXZD002"],"award-info":[{"award-number":["GSPZDXK-FJXZD002"]}]},{"name":"NATCM's Project of High-level Construction of Key TCM Disciplines","award":["GSPZDXK-FJXYB018"],"award-info":[{"award-number":["GSPZDXK-FJXYB018"]}]},{"name":"Nanjing University of Traditional Chinese Medicine College Student Innovation Training Program Plan","award":["202410315059Z"],"award-info":[{"award-number":["202410315059Z"]}]},{"name":"Nanjing University of Traditional Chinese Medicine College Student Innovation Training Program Plan","award":["202310315111Y"],"award-info":[{"award-number":["202310315111Y"]}]},{"name":"Nanjing University of Traditional Chinese Medicine College Student Innovation Training Program Plan","award":["CX10315"],"award-info":[{"award-number":["CX10315"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Atherosclerosis (AS) is the most common cardiovascular disease (CVD), despite an overall declining incidence, AS remains a leading cause of death worldwide. The ZeXieYin formula (ZXYF), one of the thirteen formulas recorded in HuangDiNeiJin, a classical book of Traditional Chinese Medicine (TCM), has previously demonstrated efficacy in reducing blood lipids and combating AS. However, the precise mechanism by which it regulates blood lipids remains unclear. Given the close correlation between bile acid metabolism and cholesterol metabolism, it is imperative to elucidate the intrinsic mechanisms through which ZXYF treats AS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Purpose of the research<\/jats:title>\n            <jats:p>This study aims to investigate the pivotal role of enterohepatic bile acid circulation in enhancing intestinal barrier function and mitigating AS by ZXYF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>The AS model was established by subjecting male ApoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice to a high-fat diet (HFD). Moreover, to determine the impact of ZXYF on the integrity of the intestinal barrier, we quantified proinflammatory cytokines using RT-qPCR and ELISA. Additionally, we identified tight-junction proteins in the ileal tissues through IF. Finally, the intestinal flora metabolite and fecal bile acid composition were analyzed using 16S rRNA analysis, untargeted metabolomics analysis, and targeted metabolomics analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The ZXYF significantly improved dyslipidemia and alleviated the formation of arterial plaques in AS mice. Furthermore, the administration of ZXYF resulted in a concurrent reduction in circulating lipopolysaccharide (LPS) levels and downregulation of pro-inflammatory cytokine mRNA expression in the ileum. Additionally, there was an enhancement observed in the expression of tight junction proteins within the intestinal tissue of AS mice. Further studies found that ZXYF significantly elevated the total bile acids (TBA) and total cholesterol (TC) levels in the fecal of AS mice. The untargeted and targeted metabolomic analyses further revealed that ZXYF exerts regulatory effects on bile acid phenotype by decreasing secondary bile acids (SBAs) levels through modulation of gut microbiota composition, such as enrichment of <jats:italic>Akkermansia<\/jats:italic> (AKK) abundance, and inhibition of enterohepatic circulation of bile acids. ZXYF specifically increased the expression of hepatic bile acid synthesis enzymes CYP7A1 by modulating the FXR\/FGF15 signaling pathway, thereby promoting enhanced de novo bile acid synthesis and facilitating cholesterol catabolic excretion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The findings of our research indicate that ZXYF exerts a defensive role in the advancement of AS. The mechanism underlying the role of ZXYF in combating AS is closely associated with gut microbiota reshaping and regulation of enterohepatic bile acid circulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13020-025-01116-y","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T09:40:02Z","timestamp":1748166002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["ZeXieYin formula alleviates atherosclerosis by regulating SBAs levels through the FXR\/FGF15 pathway and restoring intestinal barrier integrity"],"prefix":"10.1186","volume":"20","author":[{"given":"Shihan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangbo","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4894-150X","authenticated-orcid":false,"given":"Boran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"1116_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5:56.","journal-title":"Nat Rev Dis Primers"},{"key":"1116_CR2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","volume":"11","author":"M Vancamelbeke","year":"2017","unstructured":"Vancamelbeke M, Vermeire S. The intestinal barrier: a fundamental role in health and disease. Exp Rev Gastroenterol Hepatol. 2017;11:821\u201334.","journal-title":"Exp Rev Gastroenterol Hepatol"},{"key":"1116_CR3","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68:1516\u201326.","journal-title":"Gut"},{"key":"1116_CR4","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1038\/s41467-024-46336-2","volume":"15","author":"D Shin","year":"2024","unstructured":"Shin D, Kim S, Lee H, Lee H-C, Lee J, Park H-W, et al. PCSK9 stimulates Syk, PKC\u03b4, and NF-\u03baB, leading to atherosclerosis progression independently of LDL receptor. Nat Commun. 2024;15:2789.","journal-title":"Nat Commun"},{"key":"1116_CR5","doi-asserted-by":"publisher","first-page":"1021924","DOI":"10.3389\/fimmu.2022.1021924","volume":"13","author":"N Calzadilla","year":"2022","unstructured":"Calzadilla N, Comiskey SM, Dudeja PK, Saksena S, Gill RK, Alrefai WA. Bile acids as inflammatory mediators and modulators of intestinal permeability. Front Immunol. 2022;13:1021924.","journal-title":"Front Immunol"},{"key":"1116_CR6","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1038\/s41467-023-42179-5","volume":"14","author":"J Xiao","year":"2023","unstructured":"Xiao J, Dong L-W, Liu S, Meng F-H, Xie C, Lu X-Y, et al. Bile acids-mediated intracellular cholesterol transport promotes intestinal cholesterol absorption and NPC1L1 recycling. Nat Commun. 2023;14:6469.","journal-title":"Nat Commun"},{"key":"1116_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117715","volume":"323","author":"Y Sun","year":"2024","unstructured":"Sun Y, Zhang H, Liu R, Xing S, Huang R, Di D, et al. Zexieyin formula alleviates atherosclerosis with cognitive impairment: a novel role in the treatment of comorbidities and its underlying mechanisms. J Ethnopharmacol. 2024;323: 117715.","journal-title":"J Ethnopharmacol"},{"key":"1116_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172424","volume":"857","author":"Z Huang","year":"2019","unstructured":"Huang Z, Xu J, Huang X, Sun G, Jiang R, Wu H, et al. Crocin induces anti-ischemia in middle cerebral artery occlusion rats and inhibits autophagy by regulating the mammalian target of rapamycin. Eur J Pharmacol. 2019;857: 172424.","journal-title":"Eur J Pharmacol"},{"key":"1116_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117969","volume":"327","author":"R Huang","year":"2024","unstructured":"Huang R, Sun Y, Liu R, Zhu B, Zhang H, Wu H. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK\/NF-\u03baB signaling pathway in APOE\u2212\/\u2212 mice to attenuate vascular inflammation and increase plaque stability. J Ethnopharmacol. 2024;327: 117969.","journal-title":"J Ethnopharmacol"},{"key":"1116_CR10","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.3390\/molecules28052148","volume":"28","author":"L Wu","year":"2023","unstructured":"Wu L, Xi Y, Yan M, Sun C, Tan J, He J, et al. Berberine-based carbon quantum dots improve intestinal barrier injury and alleviate oxidative stress in C57BL\/6 mice with 5-fluorouracil-induced intestinal mucositis by enhancing gut-derived short-chain fatty acids contents. Molecules. 2023;28:2148.","journal-title":"Molecules"},{"key":"1116_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112705","volume":"42","author":"AS Ganapathy","year":"2023","unstructured":"Ganapathy AS, Saha K, Wang A, Arumugam P, Dharmaprakash V, Yochum G, et al. Alpha-tocopherylquinone differentially modulates claudins to enhance intestinal epithelial tight junction barrier via AhR and Nrf2 pathways. Cell Rep. 2023;42: 112705.","journal-title":"Cell Rep"},{"key":"1116_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154220","volume":"103","author":"A Wang","year":"2022","unstructured":"Wang A, Guan B, Shao C, Zhao L, Li Q, Hao H, et al. Qing-Xin-Jie-Yu Granule alleviates atherosclerosis by reshaping gut microbiota and metabolic homeostasis of ApoE-\/- mice. Phytomedicine. 2022;103: 154220.","journal-title":"Phytomedicine"},{"key":"1116_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.570555","volume":"11","author":"B Zhu","year":"2020","unstructured":"Zhu B, Zhai Y, Ji M, Wei Y, Wu J, Xue W, et al. Alisma orientalis beverage treats atherosclerosis by regulating gut microbiota in ApoE-\/- mice. Front Pharmacol. 2020;11: 570555.","journal-title":"Front Pharmacol"},{"key":"1116_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/eurheartj\/eht271","volume":"35","author":"G Rogler","year":"2014","unstructured":"Rogler G, Rosano G. The heart and the gut. Eur Heart J. 2014;35:426\u201330.","journal-title":"Eur Heart J"},{"key":"1116_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2022.101210","volume":"89","author":"S Lin","year":"2023","unstructured":"Lin S, Wang S, Wang P, Tang C, Wang Z, Chen L, et al. Bile acids and their receptors in regulation of gut health and diseases. Prog Lipid Res. 2023;89: 101210.","journal-title":"Prog Lipid Res"},{"key":"1116_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/MOL.0000000000000302","volume":"27","author":"F Schaftenaar","year":"2016","unstructured":"Schaftenaar F, Frodermann V, Kuiper J, Lutgens E. Atherosclerosis: the interplay between lipids and immune cells. Curr Opin Lipidol. 2016;27:209\u201315.","journal-title":"Curr Opin Lipidol"},{"key":"1116_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cca.2013.11.010","volume":"428","author":"X-H Yu","year":"2014","unstructured":"Yu X-H, Qian K, Jiang N, Zheng X-L, Cayabyab FS, Tang C-K. ABCG5\/ABCG8 in cholesterol excretion and atherosclerosis. Clin Chim Acta. 2014;428:82\u20138.","journal-title":"Clin Chim Acta"},{"key":"1116_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/advances\/nmz061","volume":"11","author":"MW Rohr","year":"2020","unstructured":"Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, Parthasarathy S. Negative effects of a high-fat diet on intestinal permeability: a review. Adv Nutr. 2020;11:77\u201391.","journal-title":"Adv Nutr"},{"key":"1116_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","volume":"26","author":"L An","year":"2022","unstructured":"An L, Wirth U, Koch D, Schirren M, Drefs M, Koliogiannis D, et al. The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases. J Gastrointest Surg. 2022;26:671\u201383.","journal-title":"J Gastrointest Surg"},{"key":"1116_CR20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","volume":"120","author":"WHW Tang","year":"2017","unstructured":"Tang WHW, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res. 2017;120:1183\u201396.","journal-title":"Circ Res"},{"key":"1116_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for nextgeneration beneficial microorganisms. Nat Rev Gastroenterol Hepatol. 2022;19:625\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"1116_CR22","doi-asserted-by":"publisher","first-page":"1949095","DOI":"10.1080\/19490976.2021.1949095","volume":"13","author":"J Xiang","year":"2021","unstructured":"Xiang J, Zhang Z, Xie H, Zhang C, Bai Y, Cao H, et al. Effect of different bile acids on the intestine through enterohepatic circulation based on FXR. Gut Microbes. 2021;13:1949095.","journal-title":"Gut Microbes"},{"key":"1116_CR23","doi-asserted-by":"publisher","first-page":"G55","DOI":"10.1152\/ajpgi.00476.2020","volume":"321","author":"F Stellaard","year":"2021","unstructured":"Stellaard F, L\u00fctjohann D. Dynamics of the enterohepatic circulation of bile acids in healthy humans. Am J Physiol Gastrointest Liver Physiol. 2021;321:G55-66.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"1116_CR24","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.3390\/ijms23116046","volume":"23","author":"T Katafuchi","year":"2022","unstructured":"Katafuchi T, Makishima M. Molecular Basis of Bile Acid-FXR-FGF15\/19 Signaling Axis. Int J Mol Sci. 2022;23:6046.","journal-title":"Int J Mol Sci."},{"key":"1116_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154120","volume":"101","author":"Y Fu","year":"2022","unstructured":"Fu Y, Feng H, Ding X, Meng Q-H, Zhang S-R, Li J, et al. Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis. Phytomedicine. 2022;101: 154120.","journal-title":"Phytomedicine"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01116-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01116-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01116-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T09:40:02Z","timestamp":1748166002000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01116-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01116-y","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments and procedures were granted approval by the Ethics Committee for Animal Protection of Nanjing University of Chinese Medicine (Approval No. 202209A066).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests in relation to this study. All authors have read and consented to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}